CAROAXE : revenue, balance sheet and financial ratios
CAROAXE is a French company
founded 13 years ago,
specialized in the sector Activités de santé humaine non classées ailleurs.
Based in PARIS (75009),
this company of category PME
shows in 2024 a revenue of 44 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-08-08
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
Synthèse
Santé financière :
Fragile
Signal structurel : exploitation déficitaire (EBE négatif).
In summary, CAROAXE is currently loss-making, which weighs on its accounts. Its financial structure is broadly in line with its sector.
Revenue and income statement
In 2024, CAROAXE achieves revenue of 44 k€. Revenue is declining over the period 2020-2024 (CAGR: -10.2%). Significant drop of -28% vs 2023. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches -19 k€, representing -42.6% of revenue. Warning negative scissor effect: despite revenue change (-28%), EBITDA varies by -281%, reducing margin by 59.7 pts. This reflects costs rising faster than revenue. Negative EBITDA means operations do not cover current expenses: concerning situation. Net income is negative at -26 k€ (-60.0% of revenue), which will impact equity.
Revenue (2024)
?
43 604 €
Gross margin (2024)
?
43 604 €
EBITDA (2024)
?
-18 589 €
Net income (2024)
?
-26 153 €
EBITDA margin (2024)
?
-42.6%
Loading income statement...
The detailed income statement is not available for this company (simplified accounts or confidential data).
Assets
Loading data...
Assets balance sheet data not available for this company
Liabilities
Loading data...
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 1%. This ratio is slightly less favorable than the sector median (0.1%). Financial autonomy (= Equity / Total assets x 100) reaches 1%. This ratio is slightly less favorable than the sector median (7.3%).
Debt ratio (2024)
?
1.08%
Financial autonomy (2024)
?
0.97%
Cash flow / Revenue (2024)
?
-42.82%
Repayment capacity (2024)
?
0.0
Asset age ratio (2024)
?
41.0%
| Indicator |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
| Debt ratio |
-86.448 |
109.828 |
16.023 |
7.286 |
30.938 |
16.358 |
14.797 |
4.035 |
1.076 |
| Financial autonomy |
122.837 |
37.077 |
11.661 |
6.627 |
22.372 |
12.438 |
12.167 |
3.703 |
0.97 |
| Repayment capacity |
0.0 |
0.0 |
0.0 |
0.0 |
0.784 |
1.099 |
6.58 |
0.25 |
0.0 |
| Cash flow / Revenue |
5.069% |
23.602% |
36.203% |
25.423% |
33.265% |
17.952% |
1.871% |
16.745% |
-42.822% |
Sector positioning
Q1: 0.0%
Med: 0.09%
Q3: 25.81%
Average
In 2024, the debt ratio of CAROAXE (1.1%) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Q1: 0.0%
Med: 7.28%
Q3: 60.85%
Average
In 2024, the financial autonomy of CAROAXE (1.0%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 6.55. Compared with its sector, this ratio places the company among the best positioned (sector median: 2.5).
Liquidity ratio (2024)
?
6.55
Interest coverage (2024)
?
-0.44
| Indicator |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
| Liquidity ratio |
0.25355 |
1.4474 |
3.1747 |
9.91324 |
6.71647 |
6.57203 |
6.19404 |
41.190259999999995 |
6.54518 |
| Interest coverage |
0.0 |
0.0 |
0.0 |
0.0 |
0.86 |
-2.05 |
-16.938 |
1.784 |
-0.441 |
Sector positioning
Q1: 0.94
Med: 2.5
Q3: 5.98
Excellent
In 2024, the liquidity ratio of CAROAXE (6.55) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 2 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 8 days. Favorable situation: supplier credit is longer than customer credit by 6 days. WCR is negative (-37 days): operations structurally generate cash. Between 2021 and 2024, WCR worsened by 27 days of revenue, signaling an increased financing need.
Operating WCR (2024)
?
-4 504 €
Customer credit (2024)
?
2 j
Supplier credit (2024)
?
8 j
Inventory turnover (2024)
?
0 j
WCR in days of revenue (2024)
?
-37 j
| Indicator |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
| Operating WCR |
-13 044 € |
-12 071 € |
-13 599 € |
-2 100 € |
-9 207 € |
-11 402 € |
-2 838 € |
3 673 € |
-4 504 € |
| Inventory turnover (days) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Customer payment term (days) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
| Supplier payment term (days) |
40 |
25 |
13 |
13 |
14 |
7 |
8 |
8 |
8 |
Positioning of CAROAXE in its sector
Valuation estimate
Indicative estimate only : the number of comparable transactions in this sector is limited (23 transactions).
This range of 19 209€ to 48 318€ is provided for information purposes only and requires in-depth analysis to be confirmed.
20 380 €
Range: 19 209€ - 48 318€
NAF 5 année 2024
How is this estimate calculated?
This estimate is based on the analysis of 23 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
- EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
- Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
- Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Top companies in Activités de santé humaine non classées ailleurs
Largest companies by revenue in the sector Activités de santé humaine non classées ailleurs:
Frequently asked questions about CAROAXE
What is the revenue of CAROAXE ?
The revenue of CAROAXE in 2024 is 44 k€.
Is CAROAXE profitable?
CAROAXE recorded a net loss in 2024.
Where is the headquarters of CAROAXE ?
The headquarters of CAROAXE is located in PARIS (75009), in the department Paris.
Where to find the tax return of CAROAXE ?
The tax return of CAROAXE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does CAROAXE operate?
CAROAXE operates in the sector Activités de santé humaine non classées ailleurs (NAF code 86.90F). See the 'Sector positioning' section above to compare the company with its competitors.